Abstract:OBJECTIVE:To assess the estrogen and progestin's effect on protein expression of metastasis repression gene nm23-H1 via regulation of phosphorylation signaling in epithelial ovarian cancer cell line ES-2.METHODS:Ovarian clear cell adenocarcinom cell line ES-2 was treated by different doses of 17beta-estradiol (estrogen), medroxyprogestogen (progestin) and dimethyl sulfoxide (control group), and then the following experiments were conducted. (1) Change of the cell migration capacity after treatment with estrogen and progestin for 24 and 48 hours was measured by in vitro wound healing assay. (2) Transwell experiments were used to detect the ability of cell invasion, which was also used to inhibit the phosphorylation of protein kinase B (AKT) pathway with estrogen and progestin. (3) Change of nm23-H1, AKT and phosphorylated protein kinase B (pAKT) protein level of ES-2 cells after treated with estrogen and progestin was detected by western blot. (4) Cells were transfected with the small interfering RNA (siRNA) expression vector targeting AKT. The efficiency of cells transfected was calculated according to the number of cells with green fluorescent produced by cells transfected. Change of nm23-H1 expression was assessed.RESULTS:ES-2 cells treated with estrogen, progestin or vehicle all migrated into the wound surface after 24 and 48 hours. The migration of the cells treated with estrogen was (1.39 +/- 0.08) mm, significantly elevated (P = 0.029), and that of the cells treated with progestin was (1.96 +/- 0.07) mm, significantly decreased compared with cells treated with vehicle (P = 0.014). The cells were cultured in transwell after 24 hours. The invasion of the cells treated with estrogen was 119 +/- 13, significantly elevated (P = 0.015), and that of the cells treated with progestin was 78 +/- 8, significantly decreased compared with cells treated with vehicle (P = 0.006). Western blot results showed that 17beta-estradiol decreased nm23-H1 expression, and both effects were dose and time dependent (P = 0.020, P = 0.001). Progestin increased nm23-H1 expression in ES-2 cells, and both effects were dose and time dependent (P = 0.003, P = 0.002). 17beta-Estradiol elevated the expression of pAKT, which was also dose and time dependent (P = 0.001, P = 0.007), while progestin repressed pAKT expression which was also dose and time dependent (P = 0.012, P = 0.039). When cells were transfected with the siRNA expression vector targeting AKT, the effects of estrogen and progestin on nm23-H1 expression were both attenuated.CONCLUSIONS:Estrogen downregulates the expression of nm23-H1 via activation of the phosphorylation signaling, thus participated in the regulation of invasion and metastasis of epithelial ovarian cancer cells. Progestin upregulates the expression of nm23-H1, and might repress invasion and metastasis of tumor cells.

Role of Estrogen Receptor-Mediated Anti-Tumor Effects in U2OS Cells.

Estrogen receptor β exhibited anti-tumor effects on osteosarcoma cells by regulating integrin, IAP, NF-kB/BCL-2 and PI3K/Akt signal pathway.

Effect of 17Β-Estradiol on the Migration Ability of Human Osteosarcoma U2OS Cells

Estrogen Receptor Β Induces Autophagy of Osteosarcoma Through the Mtor Signaling Pathway.

The role of estrogen receptor alpha in mediating chemoresistance in breast cancer cells

Overexpression of ERα Inhibits Proliferation and Invasion of MKN28 Gastric Cancer Cells by Suppressing Β-Catenin

Molecular Mechanisms of Estrogen Receptor Β-Induced Apoptosis and Autophagy in Tumors: Implication for Treating Osteosarcoma

Estrogen Receptor Alpha Variant Er Alpha 46 Mediates Growth Inhibition and Apoptosis of Human Ht-29 Colon Adenocarcinoma Cells in the Presence of 17 Beta-Oestradiol

Function of Estrogen Receptor Isoforms Α and Β in Endometrial Carcinoma Cells

Re-expression of Estrogen Receptor Β Inhibits the Proliferation and Migration of Ovarian Clear Cell Adenocarcinoma Cells

Effects of Oestrogen on Long Noncoding RNA Expression in Oestrogen Receptor Alpha-Positive Ovarian Cancer Cells

Estrogen-independent Effects of ER-α36 in ER-negative Breast Cancer

Modulation and function of estrogen receptor isoforms alpha and beta in endometrial carcinoma cells]

[In Vitro Study of the Effects of Estrogen Receptor Beta Expression on the Biological Behavior of a Human Breast Cancer Cell Line].

[Study on the Modulation of Estrogen Receptor Isoforms Alpha in Endometrial Carcinoma Cells Using Antisense Oligodeoxyribonucleotides].

Oestrogen Receptor Alpha Mediates 17 Beta-Estradiol Enhancement Of Ovarian Cancer Cell Motility Through Up-Regulation Of Survivin Expression

Estrogen promotes tumor metastasis via estrogen receptor beta-mediated regulation of matrix-metalloproteinase-2 in non-small cell lung cancer

Important roles of estrogen receptor alpha in tumor progression and anti-estrogen therapy of pancreatic ductal adenocarcinoma

Estrogen Stimulates the Invasion of Ovarian Cancer Cells Via Activation of the PI3K/AKT Pathway and Regulation of Its Downstream Targets E-cadherin and Α-Actinin-4

Effects of Estrogen and Estrogen Receptors on Transcriptomes of HepG2 Cells: A Preliminary Study Using RNA Sequencing

[Influence of Estrogen and Progestin on Nm23-H1 Expression in Epithelial Ovarian Cancer Cell Lines Via Activation of Phosphorylation Signaling].